About Eyenuk
Eyenuk is a Healthcare company based in Los Angeles (United States) founded in 2010 by Kaushal Solanki. AI-driven retinal image analysis for diabetic retinopathy detection is developed. Eyenuk has raised $43.66 million across 18 funding rounds from investors including NIH, HHS and AXA Investment Managers. Its chief executive, as recorded, is Gaurav Agarwal. Eyenuk offers products and services including EyeArt, Eyescreen Service, and Retinal Cameras. Its focus areas include HealthTech, Clinical Labs IT, Radiology and Image Analysis. Its legal entity is Eyenuk, Inc. Its competitors include AIdoc, Lantheus and Vista.ai; 2 of its 3 listed competitors have raised funding.
Company details
Eyenuk was established in 2010 in Los Angeles, United States, within the health technology sector focused on ophthalmology. Automated analysis of retinal images is provided through machine learning to detect diabetic retinopathy lesions in fundus photographs via the EyeArt platform. Progression tracking is enabled by EyeMark, while EyeSeeAMD supports diagnosis of age-related macular degeneration. Mobile screening is facilitated by EyeApp, which integrates smartphones with compact imaging devices for on-site assessments.
- Total Equity Funding$43.66M (USD)
in 18 rounds
- Latest Funding Round$5.61M (USD), Series A
Apr 2026
- InvestorsNIH
& 6 more
Products & Services of Eyenuk
Eyenuk offers a comprehensive portfolio of products and services, including EyeArt, Eyescreen Service, and Retinal Cameras.
Autonomous AI tool for detecting diabetic retinopathy from retinal images
Provides retinal image analysis for various eye diseases
Hardware for capturing retinal images in clinical settings
Apps and channels of Eyenuk
its YouTube channel Eyenuk, Inc. has 131 subscribers and 9 videos.
Videos from Eyenuk
The most watched videos on Eyenuk's YouTube channel, Eyenuk, Inc. (131 subscribers). Click a video to play it here.
More on Eyenuk, Inc..
Funding Insights of Eyenuk
Eyenuk has successfully raised a total of $43.66M across 18 strategic funding rounds. The most recent funding activity was a Series A round of $5.61 million completed in April 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $43.66M
- Total Rounds 18
- Last Round Series A — $5.61M
- First Round $788,719
(Jul 2011)
- Investors Count 7
Latest 10 of 18 funding rounds of Eyenuk with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2026 | $5.61M | Series A | – | – | – |
| Aug 2022 | $26M | Series A | – | AXA Investment Managers | |
| Jul 2021 | $6.2M | Series A | – | AXA Investment Managers | – |
| Oct 2019 | Grant | – | – | ||
| Sep 2019 | $442,749 | Grant | – | – | |
| Jun 2018 | $2.21M | Grant | – | – | |
| Apr 2018 | $3M | Series A | – | – | – |
| Oct 2017 | $1.35M | Seed | – | – | – |
| Sep 2016 | $1.5M | Grant | – | – | |
| Aug 2016 | $1.5M | Grant | – | – |
7 investors in total: 7 institutional.
Investors in Eyenuk
Eyenuk has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include NIH, HHS and AXA Investment Managers.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Diversified alternative assets are managed through investment strategies. | 1994 | axa-im.com | Puteaux, France | |
Venture capital investments are focused on health technology breakthroughs. | kcpventures.com | Boston, United States | ||
Kofa Healthcare is engaged in funding healthcare and biotech innovations. | kofahealthcare.com | |||
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Eyenuk
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Eyenuk
5 people are tracked at Eyenuk (3 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
Kaushal Solanki | Founder | Leadership |
Gaurav Agarwal | CEO | Leadership |
Greg Russell | Head of Clinical Development | Leadership |
William Dallman | Manager - Clinical And Commercial Operations | Team |
Kunal G. | Clinical Trial Manager | Team |
Complete people profiles for Eyenuk
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Eyenuk
3 dated milestones of Eyenuk across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Eyenuk is founded.
- Funding First funding round of $789K.
- Funding Latest funding round, Series A, of $5.6M.
Competitors of Eyenuk
Eyenuk has 3 listed competitors in our database, 2 of them funded. They include AIdoc, Lantheus and Vista.ai.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aidoc.com | 2016 | New York, United States | $424.5M | AI-based single-screen system is provided to streamline medical imaging. | ||
| lantheus.com | 2008 | Billerica, United States | 834 | Developer of diagnostic imaging agents and targeted therapeutics | ||
| vista.ai | 2012 | Palo Alto, United States | $8.7M | 13 | AI-guided software is utilized to automate MRI exams for clinicians. |
Detailed competitors of Eyenuk
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Eyenuk
The website of Eyenuk (eyenuk.com) receives about 5.7K visits a month.
- Monthly visits5.7K
▲ 9.5% vs previous month
Websites whose visitors overlap most with Eyenuk. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| retinsight.com | 100% | 3.6K | #4,589,738 | View details | |
| retinai.com | 98% | 5.8K | #3,370,310 | View details | |
| useocular.com | 97% | 5.8K | #3,743,270 | View details | |
myeyes.ai | myeyes.ai | 89% | #4,007,112 | – |
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Eyenuk (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Eyenuk
Complete news archive for Eyenuk
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Eyenuk
Eyenuk was founded in 2010 and raised its 1st funding round 1 year after it was founded.
Eyenuk is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
Gaurav Agarwal is the CEO of Eyenuk, as recorded in our data.
Eyenuk is a funded company, having raised a total of $43.66M across 18 funding rounds to date. The company's 1st funding round was a Grant of $1.5M, raised on Jul 2011.
Eyenuk was established in 2010 in Los Angeles, United States, within the health technology sector focused on ophthalmology. Automated analysis of retinal images is provided through machine learning to detect diabetic retinopathy lesions in fundus photographs via the EyeArt platform. Progression tracking is enabled by EyeMark, while EyeSeeAMD supports diagnosis of age-related macular degeneration. Mobile screening is facilitated by EyeApp, which integrates smartphones with compact imaging devices for on-site assessments.
Eyenuk offers EyeArt, Eyescreen Service, and Retinal Cameras.
Eyenuk has 7 investors. Key investors include NIH, HHS, AXA Investment Managers, T&W Medical A/S, and Kendall Capital Partners.
Eyenuk operates through Eyenuk, Inc..